Delivery Order SPE2DB22D1202-SPE2DB24FUSC6
Award Date
3/1/24
Potential Completion Date
3/4/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.45, is for the delivery of 4,562,229,924 units of moxifloxacin hydrochloride 400 mg tablets. The order was placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC...
This is a $7,322.68 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,822,384 units of the drug moxifloxacin hydrochloride 400 mg tablets, with a period of performance through April 8, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a $1,419.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,063,062 tablets of the antibiotic moxifloxacin hydrochloride 400 mg, with a completion date of December 12, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,567,320,273 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 20, 2025. The contract is a Delivery Order with a Firm Fixed Price of $2,691.00 and a completion date of February 21, 2025. The contract does not have a set-aside designation. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.50 firm fixed-price contract provides for the delivery of 4,567,606,290 units of the medication moxifloxacin hydrochloride 400 mg tablets. The contract has a period of performance through March 19, 2025 and is not designated as a set-aside procurement. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,565,350 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a firm fixed price of $1,290.39. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,335.44, is for the delivery of 4,566,690,552 units of the pharmaceutical product MOXIFLOXACIN HCL 400 MG TABLET 30S. The contract has a firm-fixed price pricing structure and a performance period running through December 12, 2024. This delivery order is part of a larger Indefinite Delivery...
This federal contract award, valued at $1,781.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,039,055 units of the medication moxifloxacin hydrochloride 400 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of December 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,824.02 delivery order contract is for the supply of 4,563,893,560 units of Moxifloxacin HCL 400 mg Tablets in 50-count units. The contract has a firm fixed price and a completion date of March 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,954,858 units of Moxifloxacin HCL 400 mg tablets. This $1,011.77 firm fixed price award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals...